Roopa Sethi, MD

Department of Addiction Psychiatry, University of Kansas Health System, Kansas City, Kansas; Department of Psychiatry and Behavioral Sciences, University of Kansas Medical Center, Kansas City, Kansas; Corresponding Author: Roopa Sethi, MD, Department of Psychiatry and Behavioral Sciences, University of Kansas Medical Center, 3901 Rainbow Blvd, Mail Stop 4015, Kansas City, KS 66160 ([email protected]).

PCC
Fentanyl-Contaminated Oxycodone
Narrative Review

November 9, 2023

The growing use of fentanyl-contaminated products is fueling the US opioid crisis. This study reviewed the rising prevalence of nonprescription fentanyl in counterfeit oxycodone, paying specific attention to oxycodone...
Grace E. Hartmann, Roopa Sethi
PCC
Xylazine as a Fentanyl Adulterant in the US
Narrative Review

October 31, 2023

Data obtained from studies between 2006 and 2022 indicate a rapidly increasing incidence of xylazine overdose in the United States, with overdose cases now being seen in 25 states.
Caitlin E. Leconte, Roopa Sethi
PCC
Opioid Use Disorder and Its Treatment in the Elderly
Systematic Review

January 10, 2023

OUD may be particularly problematic in the elderly due to age-related pain syndromes and comorbidities that increase the risk of side effects, overdose, and death. This review assessed the...
Jaya Sri Konakanchi, Roopa Sethi
PCC
Rapid Microinduction of Buprenorphine in OUD
Case Report

December 27, 2022

This is the case of a patient who was transitioned from agonist therapy with methadone to sublingual buprenorphine in an outpatient setting in just 3 days.
Iryna Salapenka, Jaya Sri Konakanchi, Roopa Sethi
PCC
Case Report

November 24, 2021

There are multiple factors to consider while initiating medications for opioid use disorder. Mr A is a 66-year-old man with a 17-year history of opioid use for pain management...
Charn Grewal, Adam Wetzel, Dheepthi Arakonam Ravishankar, et al
PCC
Case Report

February 18, 2021

This case report demonstrates the use of benzodiazepines to alleviate the withdrawal symptoms of phenibut in a 26-year-old man who visited the emergency department multiple times.
Roopa Sethi, Dheepthi Arakonam Ravishankar, Radha Nagireddy
PCC
Case Report

September 10, 2020

Here, read about the case of a 73-year-old man who developed hypotension, bradycardia, and possible respiratory depression following buprenorphine induction for opioid withdrawal.
Annelise Chaparro, Dheepthi Arakonam Ravishankar, Roopa Sethi
PCC
Case Report

April 23, 2020

Could prednisone therapy for Crohn's disease enhance buprenorphine metabolism, ultimately leading to a false-negative urine drug screen? Read this interesting case report to find out more.
Cooper D. Rodgers, Muhammad I. Gul, Roopa Sethi
PCC
Case Report

February 20, 2020

Read a case report to find out more about Tapentadol and how it is often used for pain management, with low abuse potential.
Brant S. Ansley, Roopa Sethi
PCC
Review Article

January 30, 2020

Kratom has gained popularity as an inexpensive and accessible alternative to manage symptoms of opioid use disorder and pain. But, is it safe? This review provides the most up-to-date...
Roopa Sethi, Nguyen Hoang, Dheepthi Arakonam Ravishankar, et al
PCC
Case Report

October 17, 2019

Buprenorphine is becoming the preferred treatment in pregnancy for opioid use disorder. But, women may need higher doses and multiple dosing schedules as pregnancy progresses to mitigate withdrawal symptoms...
Christopher R. Hollabaugh, Brannon Donovan, Salma Velazquez, et al
PCC
Case Report

July 18, 2019

The opioid epidemic is receiving extensive attention and is largely attributed to a rise in nonmedical uses of prescription opioids. This case report highlights a dangerous new way some...
Roopa Sethi, Joey Luvisi, Kyle Ahonen, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe